214 related articles for article (PubMed ID: 18426762)
1. [Long-term survival after nasal NK/T cell lymphoma].
Rajnics P; Krenács L; Kenéz A; Járay Z; Bagdi E; Demeter J
Orv Hetil; 2008 Apr; 149(17):801-5. PubMed ID: 18426762
[TBL] [Abstract][Full Text] [Related]
2. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
4. Extranodal NK/T-cell lymphoma, nasal type presenting as a pyogenic granuloma-like on a fingertip.
Fernández-Torres R; Del Pozo J; Alvarez A; Mazaira M; Varela C; Almagro M; Fonseca E
Eur J Dermatol; 2009; 19(1):79-80. PubMed ID: 19171539
[No Abstract] [Full Text] [Related]
5. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
7. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162
[No Abstract] [Full Text] [Related]
8. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
Kost Al M; Kost Alová M; Belada D; Laco J
Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492
[No Abstract] [Full Text] [Related]
9. Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Ogura M; Ishida T; Tsukasaki K; Takahashi T; Utsunomiya A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):199-207. PubMed ID: 27289375
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
11. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
[TBL] [Abstract][Full Text] [Related]
12. Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.
Widmer S; Tinguely M; Egli F; Thiel MA
Klin Monbl Augenheilkd; 2005 Mar; 222(3):255-7. PubMed ID: 15785994
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
14. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
17. Nasal T cell lymphoma: a rare entity.
Kazi M; Ikram M; Junaid M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S50-1. PubMed ID: 24718007
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
19. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
[TBL] [Abstract][Full Text] [Related]
20. Nasal natural killer-cell lymphoma: a disease with very poor prognosis.
Mikhaeel NG; Spittle MF
Clin Oncol (R Coll Radiol); 2000; 12(5):295-7. PubMed ID: 11315713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
